Women Health Market Growth Prospects for 2014 to 2018 Analyzed and Forecasts a New Research Report at Sandlerresearch.org

Global Women’s Health Market 2014-2018 report calculates the market size by considering revenue generated from the sales of various products based on their application segment Postmenopausal Osteoporosis (Drugs), Hormonal Contraceptives (Drugs and Devices), Menopause (Drugs), Infertility (Drugs), Endometriosis (Drugs), and Polycystic Ovary Syndrome (Drugs).

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Dallas, Texas (PRWEB) July 17, 2014

In the recent past, vendors have entered into several agreements or partnerships to develop or introduce new products or drugs in the Global Women's Health market. Some of the major acquisitions include Conceptus by Bayer, Warner Chilcott by Actavis, Uteron Pharma by Watson Pharmaceuticals, and Barr Pharmaceuticals by Teva Pharmaceutical. Some of the other prominent collaborations include Bayer with EndoCeutics to develop Vaginorm for treatment of vaginal atrophy, AbbVie with Neurocrine Biosciences to develop and commercialize Elagolix, and all next-generation GnRH antagonists for women's and men's health.

According to the report, the growth of the Global Women Health market is curtailed by some serious challenges. One of the main challenges is the patent expiry of major blockbuster drugs during the forecast period. Some of the patent expiries of top leading products include Bayer’s Mirena and Yaz, Eli Lilly's Evista, and F. Hoffmann-La Roche's Boniva.

The report covers the present scenario and the growth prospects of the Global Women’s Health market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for the well being of women, which are listed below based on their application segment:

  •     Postmenopausal Osteoporosis (Drugs)
  •     Hormonal Contraceptives (Drugs and Devices)
  •     Menopause (Drugs)
  •     Infertility (Drugs)
  •     Endometriosis (Drugs)
  •     Polycystic Ovary Syndrome (Drugs)
The Global Women’s Health Market 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA, and the APAC regions; it also covers the Global Women’s Health market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Purchase Report @ http://www.sandlerresearch.org/purchase?rname=19375

The report recognizes the following companies as the key players in the Glob.al Women's Health Market: Actavis plc, Bayer AG , Eli Lilly and Co., Merck & Co., Pfizer Inc. , AbbVie Inc., Adamis Pharmaceuticals Corp., Agile Therapeutics Inc., Amgen Inc., ANI Pharmaceuticals Inc., ApothecusPharmaceutical Corp., AstraZeneca plc, Blairex Laboratories Inc., Catalysis SL, Crinetics Pharmaceuticals Inc., Dexa Medica Group, EffRx Inc., Ferring International Center SA, GlaxoSmithKline plc, HLL Lifecare Ltd., Janssen Pharmaceutical Inc., Ligand Pharmaceuticals Inc., Lipocine Inc., Lupin Pharmaceuticals Inc., Mayer Laboratories, Medicines 360,Mylan Laboratories Inc., Neurocrine Biosciences Inc., Pantarhei Bioscience BV, and Teva Pharmaceuticals Inc.

Key Market Driver

  •     Increase in Aging Female Population
Key Market Challenge
  •     Patent Expiry of Major Blockbuster Drugs
Key Market Trend
  •     Rise in Strategic Partnerships
Further, the report states that the growth of the Global Women's Health market is curtailed by some serious challenges. One of the main challenges is the patent expiry of major blockbuster drugs during the forecast period. Some of the patent expiries of top leading products include Bayer’s Mirena and Yaz, Eli Lilly's Evista, and F. Hoffmann-La Roche's Boniva.

Key Questions Answered in this Report

  •     What will the market size be in 2018 and what will the growth rate be?
  •     What are the key market trends?
  •     What is driving this market?
  •     What are the challenges to market growth?
  •     Who are the key vendors in this market space?
  •     What are the market opportunities and threats faced by the key vendors?
  •     What are the strengths and weaknesses of the key vendors?
Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1.1 Postmenopausal Osteoporosis
07.1.2 Hormonal Contraceptives
07.1.3 Menopause
07.1.4 Infertility
07.1.5 Endometriosis
07.1.6 Polycystic Ovary Syndrome
08. Global Postmenopausal Osteoporosis Market
08.1 Market Overview
08.2 Market Size and Forecast
09. Global Hormonal Contraceptives Market
09.1 Market Overview
09.2 Market Size and Forecast
10. Global Menopause Market
10.1 Market Overview
10.2 Market Size and Forecast
11. Global Infertility Market
11.1 Market Overview
11.2 Market Size and Forecast
12. Global Endometriosis Market
12.1 Market Overview
12.2 Market Size and Forecast
13. Global Polycystic Ovary Syndrome Market
13.1 Market Overview
13.2 Market Size and Forecast
14. Geographical Segmentation
15. Buying Criteria
16. Market Growth Drivers
17. Drivers and their Impact
18. Market Challenges
19. Impact of Drivers and Challenges
20. Market Trends
21. Trends and their Impact
22. Vendor Landscape
23. Key Vendor Analysis
24. Other Reports in this Series
29 - List of Exhibits

Explore other reports on Pharmaceutical Market, Therapeutics Market.

About Us:

Sandlerresearch.org (http://www.sandlerresearch.org/) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities, and forecasts about industries that help businesses make the right decision.


Contact

Follow us on: Contact's Google Plus

Past News Releases Group Rss Subscribe